— Know what they know.
Not Investment Advice

GRI NASDAQ

GRI Bio, Inc.
1W: -4.4% 1M: -2.0% 3M: +8.3% YTD: -75.0% 1Y: -96.5% 3Y: -100.0% 5Y: -100.0%
$1.96
+0.00 (+0.00%)
 
Weekly Expected Move ±22.4%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $4.3M mcap · 2M float · 12.10% daily turnover · Short 37% of daily vol

Balance Sheet Trends

Total Assets
$9M +51.0% ▲
5Y CAGR: +55.4%
Total Liabilities
$3M +55.7% ▲
5Y CAGR: +2.0%
Shareholders Equity
$6M +49.0% ▲
Cash & Investments
$8M +63.7% ▲
5Y CAGR: +137.5%
Total Debt
$71K -40.3% ▼
5Y CAGR: -26.7%
Net Debt
-$8M -66.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$90K$9K$2M$5M$8M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$90K$9K$2M$5M$8M
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$6K$303K$1M$587K$363K
Total Current Assets$96K$312K$3M$6M$9M
Property, Plant & Equip.$117K$71K$22K$124K$74K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$5K$0$0$0$0
Total Non-Current Assets$122K$71K$22K$124K$74K
Total Assets$218K$383K$3M$6M$9M
— Liabilities —
Accounts Payable$57K$1M$1M$897K$2M
Short-Term Debt$4M$602K$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$142K$5K$3K$0$0
Total Current Liabilities$5M$2M$3M$2M$3M
Long-Term Debt$0$0$0$0$15K
Other Non-Current Liab.$0$0$0$0-$15K
Total Non-Current Liabilities$67K$14K$0$71K$15K
Total Liabilities$5M$2M$3M$2M$3M
— Equity —
Common Stock$352K$1K$0$0$0
Retained Earnings-$15M-$18M-$32M-$40M-$52M
Accumulated OCI-$2K$0$0$0$0
Total Stockholders Equity-$5M-$2M$259K$4M$6M
Total Liabilities & Equity$218K$383K$3M$6M$9M
— Key Metrics —
Total Debt$4M$673K$14K$119K$71K
Net Debt$4M$664K-$2M-$5M-$8M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms